You are here

  • Home
  • Archive
  • Volume 106, Issue 4
  • Effects of taking pregabalin (Lyrica) on the severity of dry eye, corneal sensitivity and pain after laser epithelial keratomileusis surgery

Article info

Article menu
Download PDFPDF
Clinical science
Effects of taking pregabalin (Lyrica) on the severity of dry eye, corneal sensitivity and pain after laser epithelial keratomileusis surgery

Authors

  • Dong Won Paik Department of Ophthalmology, Sungkyunkwan University School of Medicine, Samsung Medical Center, Seoul, Korea (the Republic of) PubMed articlesGoogle scholar articles
  • Dong Hui Lim Department of Ophthalmology, Sungkyunkwan University School of Medicine, Samsung Medical Center, Seoul, Korea (the Republic of) Department of Health Sciences and Technology, Samsung Advanced Institute for Health Sciences and Technology, Seoul, Korea (the Republic of) PubMed articlesGoogle scholar articles
  • Tae-Young Chung Department of Ophthalmology, Sungkyunkwan University School of Medicine, Samsung Medical Center, Seoul, Korea (the Republic of) PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Tae-Young Chung, Ophthalmology, Samsung Medical Center, Seoul, Gangnam-gu, Korea (the Republic of); tychung{at}skku.edu
View Full Text

Citation

Paik DW, Lim DH, Chung T
Effects of taking pregabalin (Lyrica) on the severity of dry eye, corneal sensitivity and pain after laser epithelial keratomileusis surgery
British Journal of Ophthalmology 2022;106:474-479.

Publication history

  • Received July 24, 2020
  • Revised October 27, 2020
  • Accepted November 14, 2020
  • First published December 10, 2020.
Online issue publication 
March 22, 2022

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.